NASDAQ:DYAI Dyadic International Q3 2026 Earnings Date & Estimates $0.42 -0.01 (-2.19%) As of 04:00 PM Eastern This is a fair market value price provided by Massive. Learn more. Dyadic International is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. The conference call is scheduled for 5:00 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 11, 2026TimeAfter Market ClosesConference Call5:00 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from Dyadic International in Q3 2026Dyadic International is expected to post earnings of -$0.03 per share on revenue of $1.43 million. In the same quarter a year earlier Dyadic International reported -$0.06 per share on revenue of $1.16 million. Dyadic International last reported on August 12, 2026, posting -$0.06 per share and missing the -$0.0350 consensus estimate. Dyadic International has beaten the consensus EPS estimate in 1 of its last 8 quarters.Consensus EstimatesConsensus EPS-$0.03Expected Revenue$1.43 millionPrior-Year EPS-$0.06Prior-Year Revenue$1.16 millionExpected Revenue Growth+23.1%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS-$0.06 (Missed by -$0.0250)Last Quarter Revenue$0.96 millionEPS Beat Rate1 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report Dyadic International Q3 2026 Earnings FAQ When does Dyadic International report Q3 2026 earnings? Dyadic International (NASDAQ:DYAI) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it. What time is Dyadic International's Q3 2026 earnings call? Dyadic International's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 5:00 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for Dyadic International? Analysts expect Dyadic International to post earnings of -$0.03 per share for Q3 2026. How much revenue is Dyadic International expected to report? The consensus revenue estimate for Dyadic International is $1.43 million for Q3 2026. Dyadic International Earnings HeadlinesDyadic International (NASDAQ:DYAI) Stock Price Breaks Below 50 Day Moving Average - What's Next?October 13 at 3:03 AM | americanbankingnews.comHead to Head Survey: Dyadic International (NASDAQ:DYAI) versus Spyre Therapeutics (NASDAQ:SYRE)October 7, 2026 | americanbankingnews.comWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.October 14 at 1:00 AM | Brownstone Research (Ad)Dyadic International Targets Commercial Traction as Life Sciences Products LaunchOctober 4, 2026 | americanbankingnews.comHead-To-Head Review: Amylyx Pharmaceuticals (NASDAQ:AMLX) vs. Dyadic International (NASDAQ:DYAI)October 4, 2026 | americanbankingnews.comDyadic International, Inc. (DYAI) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 TranscriptSeptember 15, 2026 | seekingalpha.comSee More Dyadic International Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Dyadic International? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Dyadic International and other key companies, straight to your email. Email Address About Dyadic InternationalDyadic International (NASDAQ:DYAI), Inc. is a biotechnology company that develops microbial protein-production technologies for use in the biopharmaceutical, vaccine, industrial enzyme and food markets. Its platforms are designed to produce proteins efficiently at commercial scale, with potential applications including vaccines, therapeutic proteins, antibodies, enzymes and other biological products. The company’s principal technology is its C1 expression platform, which uses a proprietary fungal host organism to produce recombinant proteins. Dyadic also develops the Dapibus platform and related technologies intended to support the production of proteins and other biologically derived materials. The company works with commercial, academic and government partners to advance applications of its platforms. Dyadic was founded in 1979 and is headquartered in Jupiter, Florida. Its activities have expanded from industrial enzyme production into broader biotechnology and biopharmaceutical applications, serving partners and potential customers in North America, Europe and other international markets. Mark Emalfarb, the company’s founder, serves as president and chief executive officer.View Dyadic International ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Citi Stock Falls Despite Earnings Beat: What Investors Need to KnowDon’t Get NVIDIA’s Reflection AI Interest Wrong: Its Moat Could DeepenIREN Limited's AI Pivot Gains Traction—But Can Its Data Centers Deliver?PBF Energy's Stunning Rally Faces a Critical TestA Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?Albertsons Is Betting on a Turnaround—But Will It Pay Off?PepsiCo's Earnings Beat Masks a Bigger Problem With Its North American Business Upcoming Earnings Interactive Brokers Group (10/15/2026)Marsh & McLennan Companies (10/15/2026)The PNC Financial Services Group (10/15/2026)Charles Schwab (10/15/2026)U.S. Bancorp (10/15/2026)Prologis (10/15/2026)Taiwan Semiconductor Manufacturing (10/15/2026)Truist Financial (10/16/2026)Travelers Companies (10/16/2026)HDFC Bank (10/17/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
